<DOC>
	<DOCNO>NCT01736488</DOCNO>
	<brief_summary>The purpose study evaluate antihypertensive efficacy change neurohormonal marker fimasartan atenolol exaggerated blood pressure response exercise essential hypertensive patient .</brief_summary>
	<brief_title>Clinical Study Evaluate Antihypertensive Efficacy Changes Neurohormonal Markers Fimasartan Atenolol With Exaggerated Blood Pressure Response During Exercise Essential Hypertensive Patients</brief_title>
	<detailed_description>After subject sign informed consent voluntarily , take hypertension medication , go screening period 7 day include wash-out period . After screen wash-out period , subject take placebo 14 day ( Maximum 21 day ) , evaluate suitability Inclusion Exclusion criterion . Patients , evaluate proper subject clinical trial , allocate experimental group ( Fimasartan 60mg ) Control group ( Atenolol 50mg ) randomly ratio 1:1 investigational drug administer daily study period ( 8 week ) . Subjects visit investigator twice treatment period , take investigational drug 4 week , 8 week . The placebo period single-blinded treatment allocation study double-blinded .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Antihypertensive Agents</mesh_term>
	<mesh_term>Atenolol</mesh_term>
	<criteria>1 . Subjects agree participate clinical trial submit write informed consent 2 . Subjects age 20 75 year 3 . Essential hypertension patient measure 140mmHg , less 170mmHg sit systolic blood pressure ( SiSBP ) 90mmHg , less 110mmHg sit diastolic blood pressure ( SiDBP ) baseline ( Day 0 ) 4. men measure 210mmHg , woman measure 190mmHg increase 50mmHg exercise baseline ( Day 0 ) 5 . Subject consider understand clinical trial , cooperative , able followedup whole clinical trial period 1 . Patients measure difference mean blood pressure one arm sit diastolic blood pressure ( SiDBP ) 10mmHg SiSBP 20mmHg screen baseline visit 2. 170mmHg mean Sitting systolic blood pressure ( SiSBP ) 110mmHg mean Sitting diastolic blood pressure ( SiDBP ) exercise baseline ( Day 0 ) 3 . Patients secondary hypertension 4 . Patients orthostatic hypotension sign symptom 5 . Patients severe insulin dependent uncontrolled diabetes mellitus ( HbA1c &gt; 9 , regimen change oral hypoglycemic agent , use insulin ) 6 . Patients severe heart disease , ischemic heart disease within 6 month , peripheral vascular disease , Percutaneous transluminal coronary angiography ( PTCA ) , Coronary artery bypass graft ( CABG ) 7 . Patients significant ventricular tachycardia , atrial fibrillation , atrial flutter significant arrhythmia 8 . Patients hypertrophic obstructive cardiomyopathy , severe obstructive coronary artery disease , aortic stenosis , hemodynamically significant aortic valve mitral valve disease 9 . Patients severe cerebrovascular disease 10 . Patients know severe malignancy retinopathy 11 . Patients waste disease , autoimmune disease , connective tissue disease present and/or previous 12 . Patients significant investigation ; abnormal renal function ( Creatinine 1.5 time upper limit normal ) , abnormal liver function ( AST , ALT 2 time upper limit normal ) , severe fatty liver disease need medication 13 . Patients surgical medical disease able affect absorption , distribution , metabolism excretion 14 . Patients story evidence alcohol drug abuse within 2 year 15 . Childbearing breastfeed woman 16 . Female plan become pregnancy possibility pregnancy n't prevent conception acknowledge method 17 . Patients Bronchial Asthma 18 . Patients expect live less 1 year tumor chronic disease 19 . Patients hepatitis B C 20 . Patients history allergic reaction angiotensin II antagonist 21 . Patients take medicine within 12 week screen visit go progress clinical trial 22 . Subject judge unsuitable participate clinical trial investigator</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>Antihypertensive efficacy</keyword>
	<keyword>Neurohormonal marker</keyword>
	<keyword>Blood Pressure Response</keyword>
	<keyword>Exercise</keyword>
</DOC>